PEAK6 Investments’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$481K Buy
3,100
+400
+15% +$59.7K ﹤0.01% 2337
2024
Q2
$370K Sell
2,700
-900
-25% -$123K ﹤0.01% 2417
2024
Q1
$479K Sell
3,600
-54,300
-94% -$7.05M ﹤0.01% 2476
2023
Q4
$7.98M Buy
57,900
+56,900
+5,690% +$7.48M 0.03% 579
2023
Q3
$122K Sell
1,000
-43,600
-98% -$5.81M ﹤0.01% 3319
2023
Q2
$6.27M Buy
44,600
+30,500
+216% +$4.2M 0.03% 558
2023
Q1
$1.99M Sell
14,100
-91,600
-87% -$13.1M 0.01% 1310
2022
Q4
$16.5M Buy
105,700
+98,600
+1,389% +$14.2M 0.1% 211
2022
Q3
$871K Sell
7,100
-43,000
-86% -$5.66M ﹤0.01% 2334
2022
Q2
$7M Buy
50,100
+44,300
+764% +$6.04M 0.01% 1114
2022
Q1
$794K Sell
5,800
-90,700
-94% -$12.6M ﹤0.01% 2709
2021
Q4
$16.7M Buy
96,500
+83,300
+631% +$12.7M 0.04% 484
2021
Q3
$1.92M Buy
13,200
+4,100
+45% +$600K ﹤0.01% 2014
2021
Q2
$1.2M Buy
9,100
+7,500
+469% +$982K ﹤0.01% 2384
2021
Q1
$205K Sell
1,600
-54,400
-97% -$6.7M ﹤0.01% 3905
2020
Q4
$6.67M Hold
56,000
0.01% 891
2020
Q3
$6.38M Buy
56,000
+31,100
+125% +$3.67M 0.02% 820
2020
Q2
$2.84M Sell
24,900
-2,300
-8% -$244K 0.01% 1202
2020
Q1
$2.18M Buy
27,200
+12,400
+84% +$1.28M 0.01% 972
2019
Q4
$1.58M Sell
14,800
-9,300
-39% -$970K 0.01% 1258
2019
Q3
$2.57M Sell
24,100
-6,200
-20% -$636K 0.02% 1114
2019
Q2
$3.08M Buy
+30,300
New +$2.91M 0.02% 989
2018
Q4
Sell
-10,000
Closed -$1.08M 4155
2018
Q3
$1.08M Buy
+10,000
New +$1.1M ﹤0.01% 1929

Other funds holding DGX

PEAK6 Investments's DGX Position: Q3 2024 in Review

PEAK6 Investments sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 2,875 shares — an estimated $429K sold.

PEAK6 Investments first reported a position in DGX in Q3 2018 and held it in 9 quarters. The position peaked at $2.5M in Q3 2022. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

  • PEAK6 Investments reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 2,875 Quest Diagnostics shares in Q3 2024, an estimated $429K.
  • PEAK6 Investments first reported a position in Quest Diagnostics in Q3 2018 and held it in 9 quarters.
  • PEAK6 Investments's Quest Diagnostics position peaked at $2.5M in Q3 2022.
  • 847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.